Gene Therapy
Conference Coverage
Multi-Refractory MM: After Immunotherapy, What?
Experts outlined viable remaining options for treating multi-refractory myeloma, following immunotherapy.
Conference Coverage
Lymphoma Debate: CAR T Not a Clear Winner
Fiercely debating on best strategies for treating advanced lymphoma, specialists could not reach consensus.
Conference Coverage
Expert Updates Therapy for Waldenström Macroglobulinemia
A specialist applies a novel, nuanced approach to Waldenström macroglobulinemia, based on mutational status.
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Conference Coverage
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies
Survey respondents classify and grade morbilliform, psoriasiform, and papulopustular rashes based on a review of photographs and text descriptions...
Sponsored Supplement
Fundamentals of Gene Therapy: Addressing Gaps in Physician Education
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
Conference Coverage
Sickle Cell CRISPR Gene Therapy May Offer Patients ‘Functional Cure’
Patients with severe sickle cell disease aged 12 and older could benefit greatly from two newly approved gene-editing treatments.
Conference Coverage
Sickle Cell Gene Therapy ‘Truly Transformative’
New research on a just-approved gene therapy for sickle cell disease shows the efficacy of a single infusion of lovo-cel.